Proven
Vitamin C (Ascorbic Acid)
The prediction game
Call it: rising or fading?
Where does Vitamin C (Ascorbic Acid) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: B (good evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 7.7/10
Vitamin C is a 7.7 out of 10 because the floor is so high and the downside so small: it is essential, decisively effective for deficiency, very safe, and nearly free, with modest real bonuses for blood pressure, glycemia, iron absorption, and cold duration. The practical verdict is to treat it as a cheap nutritional insurance policy rather than a hero supplement. It belongs in the strong-recommend tier not because it transforms healthy people, but because ensuring adequacy is genuinely valuable and the risk of doing so is almost nil. The people who should skip megadoses are healthy, well-fed adults chasing grams or IV drips for benefits the evidence does not support. ✅ Best for: People with low dietary fruit and vegetable intake, who are the clearest beneficiaries of correction. Smokers and heavy drinkers, who have measurably higher requirements. Athletes and others under heavy physical stress, where Hemila 2013 showed regular vitamin C halved cold incidence. Hypertensive adults wanting a cheap adjunct for the modest blood pressure effect from Juraschek 2012. People with type 2 diabetes, where the glycemic signal concentrates at higher doses. Vegetarians and the iron-deficient, who benefit from co-taking it with plant-based iron. The elderly, malnourished, and post-surgical, where adequate vitamin C supports wound healing. ❌ Avoid if: You have a kidney-stone history, chronic kidney disease, or oxalate-stone tendency, since supplemental doses at or above 1000 mg/day roughly doubled stone risk in men. You have hemochromatosis or another iron-overload condition, because vitamin C increases iron absorption. You have G6PD deficiency, where very high doses can trigger hemolysis. You expect grams to deliver dramatic benefits in an already-replete body, or you are considering intravenous vitamin C for cancer or sepsis on the strength of marketing, since the Fowler 2019 sepsis trial and the cancer evidence do not support those frames.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Proven
- Trend
- Begins with Edition 2
- Momentum
- 3.4%
- BioHarmony Score
- 7.7/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.